TODD ORSZULAK
Allopathic & Osteopathic Physicians|Internal Medicine NIAGARA FALLS, NY NPI 1881761864
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY Lilly USA, LLC All categories
General Payments — all program years on this page
$9,124.62
- Category: General Payments
- Program years: PY2018–2024
- Record count: 487
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,365.41 across 65 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,300.42 | 64 |
| Education | $64.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $315.65 | 13 |
| ABBVIE INC. | $178.94 | 9 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $129.89 | 6 |
| GlaxoSmithKline, LLC. | $109.73 | 6 |
| Astellas Pharma US Inc | $94.63 | 2 |
| Amgen Inc. | $86.09 | 4 |
| Exact Sciences Corporation | $55.51 | 3 |
| E.R. Squibb & Sons, L.L.C. | $49.17 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.76 | 2 |
| Acerta Pharma LLC | $45.52 | 3 |
| Mylan Specialty L.P. | $35.90 | 2 |
| Currax Pharmaceuticals LLC | $34.70 | 2 |
| Novo Nordisk AS | $32.72 | 2 |
| Grifols USA, LLC | $23.88 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.28 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.96 | 1 |
| SHIELD THERAPEUTICS INC | $18.79 | 1 |
| Janssen Pharmaceuticals, Inc | $18.64 | 1 |
| Merck Sharp & Dohme Corporation | $17.72 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.15 | 1 |
| PFIZER INC. | $14.78 | 1 |
By program year
Records — PY2024 (65)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.